Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2017-01-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00210-016-1336-1PMID 28074232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.

  2015cited by this paper
• Localization of relaxin receptors in arteries and veins, and region‐specific increases in compliance and bradykinin‐mediated relaxation after in vivo serelaxin treatment

  2014cited by this paper
• Nitroxyl donors retain their depressor effects in hypertension.

  2013cited by this paper
• Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.

  2013cited by this paper
• The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness.

  2013cited by this paper
• Nitrite- and nitroxyl-induced relaxation in porcine coronary (micro-) arteries: underlying mechanisms and role as endothelium-derived hyperpolarizing factor(s).

  2012cited by this paper
• Interaction between Advanced Glycation End Products Formation and Vascular Responses in Femoral and Coronary Arteries from Exercised Diabetic Rats

  2012cited by this paper
• Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta.

  2012cited by this paper
• Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.

  2012cited by this paper
• Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia.

  2011cited by this paper
• Impairment of both nitric oxide‐mediated and EDHF‐type relaxation in small mesenteric arteries from rats with streptozotocin‐induced diabetes

  2011cited by this paper
• A Novel Role for HNO in Local and Spreading Vasodilatation in Rat Mesenteric Resistance Arteries

  2011cited by this paper
• Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats

  2011cited by this paper
• Nitroxyl (HNO) as a Vasoprotective Signaling Molecule

  2011cited by this paper
• Chronic Administration of the HNO Donor Angeli's Salt Does Not Lead to Tolerance, Cross-Tolerance, or Endothelial Dysfunction: Comparison with GTN and DEA/NO

  2011cited by this paper
• Regulation of vascular guanylyl cyclase by endothelial nitric oxide-dependent posttranslational modification

  2011cited by this paper
• Endothelial dysfunction in diabetes: multiple targets for treatment

  2010cited by this paper
• The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity

  2009cited by this paper
• Endothelial dysfunction and vascular disease

  2009cited by this paper
• A role for nitroxyl (HNO) as an endothelium‐derived relaxing and hyperpolarizing factor in resistance arteries

  2009cited by this paper
• Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005

  2009cited by this paper
• Microvascular and Macrovascular Complications of Diabetes

  2008cited by this paper
• The Role of Advanced Oxidation Protein Products and Total Thiols in Diabetic Retinopathy

  2008cited by this paper
• Nitroxyl Anion Donor, Angeli’s Salt, Does Not Develop Tolerance in Rat Isolated Aortae

  2007cited by this paper
• Desensitization of soluble guanylyl cyclase, the NO-receptor, by S-nitrosylation

  2007cited by this paper
• The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature.

  2007cited by this paper
• Augmented Endothelium-Derived Hyperpolarizing Factor-Mediated Relaxations Attenuate Endothelial Dysfunction in Femoral and Mesenteric, but Not in Carotid Arteries from Type I Diabetic Rats

  2006cited by this paper
• Diabetes induces Na/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries.

  2005cited by this paper
• ROLE OF ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTOR IN ENDOTHELIAL DYSFUNCTION DURING DIABETES

  2005cited by this paper
• Effect of nitroxyl on human platelets function

  2005cited by this paper
• Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets.

  2005cited by this paper
• Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.

  2003cited by this paper
• NO‐ Activates Soluble Guanylate Cyclase and Kv Channels to Vasodilate Resistance Arteries

  2003cited by this paper
• Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO.

  2003cited by this paper
• Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite.

  2002cited by this paper
• Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide andnitroxyl ion

  2001cited by this paper
• Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery.

  2001cited by this paper
• Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart.

  2001cited by this paper
• Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus.

  2001cited by this paper
• Nitric Oxide‐Sensitive Guanylyl Cyclase Activity Inhibition Through Cyclic GMP‐Dependent Dephosphorylation

  2000cited by this paper
• Endothelial dysfunction in diabetes

  2000cited by this paper
• Vascular smooth muscle relaxation mediated by nitric oxide donors: A comparison with acetylcholine, nitric oxide gas and nitroxyl ion

  2000cited by this paper
• Differential actions of L‐cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta

  2000cited by this paper
• Mechanisms underlying the attenuation of endothelium‐dependent vasodilatation in the mesenteric arterial bed of the streptozotocin‐induced diabetic rat

  2000cited by this paper
• Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling.

  1999cited by this paper
• Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.

  1999cited by this paper
• Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry.

  1998cited by this paper
• Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase.

  1998cited by this paper
• No .NO from NO synthase.

  1996cited by this paper
• The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury.

  1996cited by this paper
• NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation.

  1995cited by this paper
• Hydrogen peroxide-supported oxidation of NG-hydroxy-L-arginine by nitric oxide synthase.

  1995cited by this paper
• Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase.

  1994cited by this paper
• Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine.

  1994cited by this paper
• EFFECTS OF HYDROXOCOBALAMIN AND HAEMOGLOBIN ON NO‐MEDIATED RELAXATIONS IN THE RAT ANOCOCCYGEUS MUSCLE

  1993cited by this paper
• Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.

  1991cited by this paper
• Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

  1986cited by this paper

• The protective role of endothelial GLUT1 in ischemic stroke

  2024cites this paper
• Decoding the enigmatic last gasotransmitter. The intriguing journey of HNO: from hidden origins to clues on reactivity and detection.

  2024cites this paper
• A modular scaffold for triggerable and tunable nitroxyl (HNO) generation with a fluorescence reporter.

  2023cites this paper
• Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid Arteries

  2021influential citation
• Dual-Colored Fluorescence Imaging of Mitochondrial HNO and Golgi-HNO in Mice with DILI.

  2021cites this paper
• FXYD1 Is Protective Against Vascular Dysfunction

  2021cites this paper
• Vasoprotective Actions of Nitroxyl (HNO): A Story of Sibling Rivalry

  2021cites this paper
• Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling

  2020cites this paper
• Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl

  2020cites this paper
• Basic Mechanisms of Diabetic Heart Disease.

  2020cites this paper
• Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

  2020cites this paper
• Oxymatrine ameliorates diabetes‐induced aortic endothelial dysfunction via the regulation of eNOS and NOX4

  2018cites this paper
• Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction

  2018cites this paper